Free Trial

ClearPoint Neuro Q2 2024 Earnings Report

ClearPoint Neuro logo
$16.72 -0.73 (-4.18%)
As of 02/21/2025 04:00 PM Eastern

ClearPoint Neuro EPS Results

Actual EPS
-$0.16
Consensus EPS
-$0.19
Beat/Miss
Beat by +$0.03
One Year Ago EPS
-$0.29

ClearPoint Neuro Revenue Results

Actual Revenue
$7.86 million
Expected Revenue
$7.50 million
Beat/Miss
Beat by +$360.00 thousand
YoY Revenue Growth
N/A

ClearPoint Neuro Announcement Details

Quarter
Q2 2024
Time
After Market Closes

CLPT Upcoming Earnings

ClearPoint Neuro will be holding an earnings conference call on Wednesday, February 26 at 4:30 PM Eastern. Interested parties can register for or listen to the call or dial in at 201-612-7415 using passcode "413671".

Conference Call Resources

ClearPoint Neuro Earnings Headlines

ClearPoint Neuro (CLPT) to Release Earnings on Wednesday
Watch This Robotics Demo Before March 17th
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
Solventum (NYSE:SOLV) vs. ClearPoint Neuro (NASDAQ:CLPT) Critical Analysis
See More ClearPoint Neuro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ClearPoint Neuro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ClearPoint Neuro and other key companies, straight to your email.

About ClearPoint Neuro

ClearPoint Neuro (NASDAQ:CLPT) operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

View ClearPoint Neuro Profile

More Earnings Resources from MarketBeat